Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Boettiger

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
AIDS Research and Therapy|May 10, 2017
Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settingsSasisopin Kiertiburanakul, David Boettiger, Oon Tek Ng, et al.
BMC Infectious Diseases|July 2, 2025
Disease progression & treatment need in sub-genotype C4 hepatitis B infection: a retrospective cohort study in the Northern Territory, AustraliaGenevieve E Martin, Kelly Hosking, Kelly Banz, et al.
Journal of the International AIDS Society|August 26, 2022
Virological failure and treatment switch after ART initiation among people living with HIV with and without routine viral load monitoring in AsiaSirinya Teeraananchai, Matthew Law, David Boettiger, et al.
The Lancet Regional Health. Western Pacific|July 5, 2024
Evaluating a novel model of hepatitis B care, Hep B PAST, in the Northern Territory of Australia: results from a prospective, population-based studyKelly Hosking, Paula Binks, Teresa De Santis, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
AIDS Research and Therapy|May 10, 2017
Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settingsSasisopin Kiertiburanakul, David Boettiger, Oon Tek Ng, et al.
BMC Infectious Diseases|July 2, 2025
Disease progression & treatment need in sub-genotype C4 hepatitis B infection: a retrospective cohort study in the Northern Territory, AustraliaGenevieve E Martin, Kelly Hosking, Kelly Banz, et al.
Journal of the International AIDS Society|August 26, 2022
Virological failure and treatment switch after ART initiation among people living with HIV with and without routine viral load monitoring in AsiaSirinya Teeraananchai, Matthew Law, David Boettiger, et al.
The Lancet Regional Health. Western Pacific|July 5, 2024
Evaluating a novel model of hepatitis B care, Hep B PAST, in the Northern Territory of Australia: results from a prospective, population-based studyKelly Hosking, Paula Binks, Teresa De Santis, et al.
Pageof 6